TReP-132 Controls Cell Proliferation by Regulating the Expression of the Cyclin-Dependent Kinase Inhibitors p21(WAF1/Cip1) and p27(Kip1)

Por Gizard, Florence, Robillard, Romain, Barbier, Olivier, Quatannens, Brigitte, Faucompré, Anne, Révillion, Françoise, Peyrat, Jean-Philippe, Staels, Bart, Hum, Dean W.
Publicado em 2005

TReP-132 Is a Novel Progesterone Receptor Coactivator Required for the Inhibition of Breast Cancer Cell Growth and Enhancement of Differentiation by Progesterone

Por Gizard, Florence, Robillard, Romain, Gross, Barbara, Barbier, Olivier, Révillion, Françoise, Peyrat, Jean-Philippe, Torpier, Gérard, Hum, Dean W., Staels, Bart
Publicado em 2006

Pan-PPAR Modulation Effectively Protects APP/PS1 Mice from Amyloid Deposition and Cognitive Deficits

Por Kummer, Markus P., Schwarzenberger, Rafael, Sayah-Jeanne, Sakina, Dubernet, Mathieu, Walczak, Robert, Hum, Dean W., Schwartz, Stephanie, Axt, Daisy, Heneka, Michael T.
Publicado no Mol Neurobiol (2014)

Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element

Por Claudel, Thierry, Sturm, Ekkehard, Duez, Hélène, Torra, Inés Pineda, Sirvent, Audrey, Kosykh, Vladimir, Fruchart, Jean-Charles, Dallongeville, Jean, Hum, Dean W., Kuipers, Folkert, Staels, Bart
Publicado em 2002